Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes
Clinical trial NCT00994292 · COMPLETED
Trial details
- NCT number
- NCT00994292
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-02-01
- Enrollment
- 1276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.